Compare IGA & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IGA | SMTI |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.5M | 169.0M |
| IPO Year | N/A | N/A |
| Metric | IGA | SMTI |
|---|---|---|
| Price | $9.93 | $18.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | 42.3K | ★ 72.9K |
| Earning Date | 01-01-0001 | 03-24-2026 |
| Dividend Yield | ★ 8.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $101,877,532.00 |
| Revenue This Year | N/A | $20.66 |
| Revenue Next Year | N/A | $17.21 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 30.52 |
| 52 Week Low | $7.77 | $18.85 |
| 52 Week High | $8.88 | $36.31 |
| Indicator | IGA | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 30.96 |
| Support Level | $9.88 | $20.12 |
| Resistance Level | $10.00 | $20.00 |
| Average True Range (ATR) | 0.09 | 1.08 |
| MACD | 0.00 | -0.15 |
| Stochastic Oscillator | 61.23 | 12.71 |
Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategies.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.